Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVES: To assess the acceptability to clinicians of a web-based decision support system designed to assist with dosage adjustments during maintenance therapy for childhood Acute Lymphoblastic Leukaemia (ALL), and to evaluate the potential impact of the system on decision-making and dosage calculations. DESIGN: Balanced-block crossover experiment with simulated cases; questionnaire study and semi-structured interviews. PARTICIPANTS: 36 clinicians with differing experience in the management of ALL. INTERVENTIONS: Subjects were asked to decide on appropriate levels of chemotherapy dosing for 8 simulated cases, 4 using the LISA decision support system, 4 using conventional paper-based records and guidance. MAIN OUTCOME MEASURES: Number of protocol-consistent dosage decisions made; time taken to manage each case; accuracy of dosage calculations; subjects' opinions as to whether or not they would use the system in practice. ADDITIONAL OUTCOME MEASURES: Functions subjects would like to see in an idealised system; subjects' satisfaction with the implementation of the functions provided by LISA; qualitative data on issues subjects felt would impact upon the successful deployment of the system.

Type

Journal article

Journal

Stud Health Technol Inform

Publication Date

2004

Volume

107

Pages

197 - 201

Keywords

Antineoplastic Agents, Attitude to Computers, Cross-Over Studies, Decision Support Systems, Clinical, Drug Therapy, Computer-Assisted, Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Surveys and Questionnaires